NCT06553911 Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
| NCT ID | NCT06553911 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Huashan Hospital |
| Condition | Respiratory Infectious Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2022-04-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases, aiming to reduce the time doctors spend reviewing images, increase work efficiency, and enhance the sensitivity and specificity of pneumonia detection, thereby improving the detection rate of pneumonia at the grassroots level. This approach facilitates precise prevention, accurate diagnosis, and precise treatment.
Eligibility Criteria
Inclusion Criteria: 1. 1-90 years old, gender not specified. 2. Exhibits symptoms of respiratory tract infection 3. Must have etiological examination results 4. Must have imaging data; Exclusion Criteria: 1. Severe artifacts in medical images 2. Clinical diagnosis indicates concurrent pulmonary edema 3. Dual review results in unclear diagnosis or potential misdiagnosis 4. Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06553911 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 90 Years, studying Respiratory Infectious Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06553911 currently recruiting?
Yes, NCT06553911 is actively recruiting participants. Contact the research team at zhangwenhong@fudan.edu.cn for enrollment information.
Where is the NCT06553911 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06553911 clinical trial?
NCT06553911 is sponsored by Huashan Hospital. The trial plans to enroll 2,000 participants.